leisure time -WSS

leisure time

author：knowledge 2025-09-30 18:59:44 - browse：9994

David Sabatini at home — David Sabatini posed at his home in Cambridge in 2022. Craig F. Walker/Boston Globe

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his lofty positions after being accused of violating sexual harassment policies in 2021, is rejoining the Boston scientific community as head of a research group at a new laboratory under the umbrella of a Czech-based scientific institute.

Sabatini, who has denied harassing anyone and filed litigation over the claims, has been working since last October in a senior research position at the Institute of Organic Chemistry and Biochemistry, in the Czech Republic capital of Prague, investigating scientific questions in the areas of cell growth and metabolism, similar to his past research at Whitehead.

The Czech institute, known as IOCB Prague, is realizing a long-held ambition to expand into the Boston biotech hub, confirmed the institute’s director, Jan Konvalinka.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： The creative science of coining drug names

focus

WSS

As billionaires fund anti

BIO to announce reorganization, senior leaders expected to depart

Statins may not be needed by millions of people, study suggests

New report analyzes digital physical therapy solutions' effectiveness

PBM executives asked to testify by House panel

Pharma companies must ensure equitable access to obesity drugs

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

After affirmative action ruling, medical educators look to 'holistic review'

AltruBio raises $225 million to develop ulcerative colitis drug

Hepatitis C has a cure — but many Americans still lack access to it

HHS's proposed rule does nothing to address the climate crisis

DIEP, the 'gold standard' of breast reconstruction, is under threat

Brain MRIs reveal impact of 'toxic stress' on Black children

Medical leaders decry Supreme Court decision on affirmative action

Is it ever OK for doctors to lie to their patients?

Novavax promises a turnaround & Lilly roils the obesity market

Can gargling with Listerine treat gonorrhea of the mouth?

hotspot

Welsh Carson private equity firm escapes from FTC antitrust case

Brain MRIs reveal impact of 'toxic stress' on Black children

Statins may not be needed by millions of people, study suggests

Class action alleges UnitedHealth concealed DOJ probe

Is it ever OK for doctors to lie to their patients?

5 takeaways from STAT's examination of Zynex Medical

focus

focus

leisure time

Wikipedia